1)Song JC, Wang G, Zhang W, et al. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Mil Med Res. 2020;7(1):19. doi:10.1186/s40779-020-00247-7
2) World Health Organization (2020). Novel Coronavirus (2019- nCoV) situation reports [online]. Website: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200523-covid-19-sitrep-124.pdf?sfvrsn=9626d639_2 [accessed 23 May 2020].
3) Ding YQ, Bian XW. Analysis of coronavirus disease-19 (covid-19). Chin J Pathol.
2020;49(00):E003. https://doi.org/10.3760/cma.j.issn.0529-5807.2020.0003.
4) Expert Group on Novel Coronavirus Disease Clinical Treatment in Shanghai. Expert consensus on comprehensive treatment of 2019 coronavirus in Shanghai. Chin J Infect dis. 2020;1:38. https://doi.org/10.3760/cma.j.issn.1000-6680.2020.0016.
5) Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846‐848. doi:10.1007/s00134-020-05991-x
6) Warkentin TE. Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia. ThrombHaemost. 2016;116(5):813–22.
7) Salter B, Weiner M, Trinh M, et al. Heparin-induced thrombocytopenia: a comprehensive clinical review. J Am Col Cardiol. 2016;67:2519–32.
8) Lo GK, Juhl D, Warkentin TE, et al. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–765.
9) Pishko AM, Cuker A. Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients. Semin Thromb Hemost. 2017;43(7):691‐698. doi:10.1055/s-0037-1602664
10) Turkey Ministry of Health (2020). COVID-19 (SARS-CoV-2 ENFEKSİYONU)(Bilim Kurulu Çalışması) [online]. Website: https://covid19bilgi.saglik.gov.tr/depo/rehberler/covid-19-rehberi/COVID-19_REHBERI_ANTISITOKIN-ANTI_INFLAMATUAR_TEDAVILER_ KOAGULOPATI_YONETIMI.pdf [accessed 07June 2020].
11) Gameiro J, Jorge S, Lopes JA. Haemodialysis-related-heparin-induced thrombocytopenia: Case series and literature review. Nefrologia. 2018;38(5):551‐557. doi:10.1016/j.nefro.2018.02.010
12) Liu X, Zhang X, Xiao Y, et al. Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment. medRxiv 2020 (In press). DOI:10.1101/2020.04.23.20076851
13) He Y, He H, Liu D, et al. Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report. Medicine (Baltimore). 2018;97(37):e12236. doi:10.1097/MD.0000000000012236